Since enalapril, sildenafil, and fenofibrate could target VEGFA and increase the expression levels of VEGFA, application of these drugs may reverse the abnormally downregulated VEGFA, thereby delaying the deterioration of renal function and providing new therapeutic targets for DN. Here, VEGFA is linked to liver dysplastic nodule.